Browse by Day Archive
Sanofi, Regeneron expand tie-up with $8 billion drug-development deal, settle legal dispute
09/30/2026 11:16pm
Sanofi and Regeneron said on Thursday they will develop four new drugs together in a deal worth up to $8 billion and settle prior litigation, moves analysts said signal a reset of their strained partnership and an early win for the French drugmaker's new CEO Belen Garijo.
In the kitchen, Gabby finds joy after years in foster care
09/30/2026 4:58pm
Sixteen-year-old Gabby, who has lived in five foster homes, finds comfort in cooking and hopes to find a caring family to call her own.
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial
09/30/2026 4:03pm
An experimental weight-loss drug being developed by Regeneron used in combination with Novo Nordisk's semaglutide reduced the loss of muscle mass by 50% compared with the loss seen with semaglutide alone in a study of patients with obesity, according to data being presented at a medical meeting.
Walgreens-owner Sycamore nears $9 billion sale of Boots, WSJ reports
09/30/2026 12:50pm
Walgreens-owner Sycamore Partners is close to a deal to sell British pharmacy chain Boots to the Weston family for about $9 billion, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Experimental Lilly combination drug tops Zepbound in weight-loss trial
09/30/2026 8:16am
Eli Lilly said on Wednesday its experimental combination weight-loss drug outperformed its blockbuster Zepbound in a head-to-head trial, intensifying the competition with Danish rival Novo Nordisk for new, more effective obesity therapies.
Merck's experimental skin disease drug succeeds in mid-stage study
09/30/2026 6:25am
Merck said on Wednesday its experimental drug significantly reduced inflammatory skin lesions in patients with a chronic skin disease, meeting the main goal of a mid-stage study.
Cigna expects $3 billion in cost savings by 2030
09/30/2026 5:56am
(Corrects headline and paragraph 1 to clarify that Cigna is not investing $3 billion, but expecting that amount in cost savings by 2030)
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study
09/30/2026 3:46am
Patients who switched from weight-loss injections to Novo Nordisk's daily Wegovy pill continued to lose weight, according to data unveiled at a medical meeting on Wednesday, as the Danish drugmaker seeks to defend its lead over US rival Eli Lilly in the market for oral obesity treatments.
Gerresheimer's quarterly sales recovery boosts shares
09/30/2026 1:19am
Gerresheimer reported a sequential recovery in its second-quarter revenue on Wednesday, sending its shares 8% higher in early trading, as demand for its drug delivery devices boosted sales.
